Profit Investment Management’s Charles River Laboratories CRL Stock Holding History

Profit Investment Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-18,900	Closed	-$1.2M	–	107
2015 Q3	$1.2M	Sell	18,900 -2,200	-10%	-$158K	0.17%	92
2015 Q2	$1.48M	Hold	21,100	–	–	0.17%	85
2015 Q1	$1.67M	Hold	21,100	–	–	0.09%	103
2014 Q4	$1.34M	Hold	21,100	–	–	0.07%	111
2014 Q3	$1.26M	Hold	21,100	–	–	0.07%	112
2014 Q2	$1.13M	Hold	21,100	–	–	0.05%	118
2014 Q1	$1.27M	Hold	21,100	–	–	0.06%	113
2013 Q4	$1.12M	Hold	21,100	–	–	0.05%	116
2013 Q3	$976K	Hold	21,100	–	–	0.04%	120
2013 Q2	$866K	Buy	+21,100	New	+$904K	0.04%	123

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Profit Investment Management's CRL Position: Q4 2015 in Review

Profit Investment Management sold out of Charles River Laboratories (CRL) in Q4 2015, closing a stake of 18,900 shares — an estimated $1.2M sold.

Profit Investment Management first reported a position in CRL in Q2 2013 and held it in 10 quarters. The position peaked at $1.67M in Q1 2015. 268 funds tracked by Wall St. Rank hold CRL as of Q4 2015.

Profit Investment Management reported no remaining Charles River Laboratories position as of Q4 2015 after selling out during the quarter.
Profit Investment Management sold 18,900 Charles River Laboratories shares in Q4 2015, an estimated $1.2M.
Profit Investment Management first reported a position in Charles River Laboratories in Q2 2013 and held it in 10 quarters.
Profit Investment Management's Charles River Laboratories position peaked at $1.67M in Q1 2015.
268 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2015.

Based on Profit Investment Management's 13F filing for Q4 2015, filed 14 Jan 2016.